Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
3.050
+0.010 (0.33%)
At close: Apr 9, 2026, 4:00 PM EDT
3.110
+0.060 (1.97%)
After-hours: Apr 9, 2026, 7:52 PM EDT
Anavex Life Sciences Employees
Anavex Life Sciences had 34 employees as of September 30, 2025. The number of employees decreased by 8 or -19.05% compared to the previous year.
Employees
34
Change (1Y)
-8
Growth (1Y)
-19.05%
Revenue / Employee
n/a
Profits / Employee
-$1,174,912
Market Cap
282.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 34 | -8 | -19.05% |
| Sep 30, 2024 | 42 | 2 | 5.00% |
| Sep 30, 2023 | 40 | 2 | 5.26% |
| Sep 30, 2022 | 38 | 13 | 52.00% |
| Sep 30, 2021 | 25 | 5 | 25.00% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| LENZ Therapeutics | 152 |
| Foghorn Therapeutics | 106 |
| C4 Therapeutics | 104 |
| Silence Therapeutics | 88 |
| Editas Medicine | 87 |
| SAB Biotherapeutics | 86 |
| Protara Therapeutics | 46 |
AVXL News
- 2 days ago - Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 10 days ago - Anavex Life Sciences Provides Comprehensive Regulatory Update - GlobeNewsWire
- 15 days ago - Anavex Life Sciences Stock Crushed As European Alzheimer's Drug Filing Pulled After EMA Pushback - Benzinga
- 15 days ago - Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer's Disease - GlobeNewsWire
- 17 days ago - Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer's Disease - GlobeNewsWire
- 20 days ago - New Scientific Findings Highlight Hypothesis of Autophagy Failure as a Precursor of Amyloid Beta and Tau Pathology in Alzheimer's Disease - GlobeNewsWire
- 23 days ago - Anavex Life Sciences Presents Significant Treatment Effects of Blarcamesine in New Advanced Alpha-Synuclein Model of Parkinson's Disease at AD/PD 2026 Conference - GlobeNewsWire
- 5 weeks ago - Anavex Life Sciences to Present at the Citizens Life Sciences Conference - GlobeNewsWire